data_1bhu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1bhu _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.466 ' N ' ' HB2' ' A' ' 41' ' ' ALA . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.339 0.114 . . . . 4.5199999999999996 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 42.3 Cg_endo -70.77 67.26 2.34 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.973 1.512 . . . . 3.2200000000000002 110.662 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.437 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 45.1 m -102.73 -10.97 18.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.967 -1.083 . . . . 2.2599999999999998 111.981 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -64.99 166.63 11.83 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.964 -1.085 . . . . 1.21 110.116 179.542 -132.006 -110.009 -168.068 116.8 2.478 120.178 76.172 56.588 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.7 ' HD2' ' SG ' ' A' ' 10' ' ' CYS . 55.0 Cg_endo -81.28 -111.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.559 1.726 0 O-C-N 122.936 0.966 . . . . 1.8999999999999999 110.305 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.614 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . . . -176.64 139.1 0.3 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.663 -1.273 . . . . 2.8799999999999999 110.208 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.585 ' C ' ' HA3' ' A' ' 49' ' ' GLY . . . 146.35 -39.42 1.11 Allowed Glycine 0 N--CA 1.51 3.595 0 C-N-CA 120.135 -1.031 . . . . 0.55000000000000004 111.392 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 25' ' ' PRO . 17.9 m -152.33 172.28 16.71 Favored 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 106.554 -1.647 . . . . 0.93000000000000005 106.554 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.776 ' HB3' ' HB ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -76.52 74.28 3.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.752 -1.179 . . . . 1.3200000000000001 108.774 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 1.107 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 24.3 p -78.79 93.46 4.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.796 -1.19 . . . . 0.34000000000000002 111.122 -178.482 56.588 76.172 -168.068 120.178 2.478 116.8 -110.009 -132.006 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.639 ' HA ' ' HB3' ' A' ' 46' ' ' PHE . 21.1 p -77.23 150.29 35.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.671 -0.643 . . . . 1.1499999999999999 109.87 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.785 ' CG ' ' HA ' ' A' ' 17' ' ' LEU . 51.5 p90 -160.16 154.02 22.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.773 -1.205 . . . . 2.1899999999999999 112.375 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 43' ' ' ALA . 4.0 p -112.52 66.97 0.65 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.253 0.549 . . . . 1.29 110.085 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 32.41 0.05 OUTLIER Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.489 -1.339 . . . . 0.89000000000000001 112.554 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' HA ' ' HE2' ' A' ' 12' ' ' TYR . 5.6 p 39.7 104.98 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.444 0 CA-C-N 118.562 1.181 . . . . 1.5800000000000001 113.583 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 3' ' ' SER . . . 113.41 28.19 3.36 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.169 -1.972 . . . . 0.71999999999999997 108.169 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.792 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 58.63 21.14 8.42 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.482 1.134 . . . . 1.99 109.325 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 35.2 t -98.65 -155.01 0.48 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 1.79 111.223 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.15 -132.27 33.42 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 109.064 -1.614 . . . . 0.80000000000000004 109.064 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 12' ' ' TYR . . . -74.0 71.22 1.57 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.931 -1.335 . . . . 1.1799999999999999 108.451 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.0 124.18 28.01 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.066 0.936 . . . . 3.4500000000000002 113.048 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.65 165.74 20.25 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.98 -0.748 . . . . 1.3200000000000001 108.98 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -133.48 133.64 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.39 -1.444 . . . . 1.23 112.351 -178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.776 ' HB ' ' HB3' ' A' ' 9' ' ' LEU . 6.9 mm -133.11 89.86 32.47 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 118.474 -1.29 . . . . 1.9399999999999999 110.315 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.478 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 49.3 Cg_endo -72.57 73.99 2.77 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.013 -1.572 . . . . 0.41999999999999998 108.013 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.612 ' HA ' HD21 ' A' ' 100' ' ' LEU . . . 35.1 68.92 0.18 Allowed 'General case' 0 N--CA 1.517 2.883 0 N-CA-C 109.572 -0.529 . . . . 1.1200000000000001 109.572 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 t -164.0 -52.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 O-C-N 120.822 -1.174 . . . . 1.8200000000000001 111.298 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.663 ' HB2' ' CG2' ' A' ' 24' ' ' ILE . 3.3 m-20 -69.94 -26.03 63.94 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.263 -1.755 . . . . 1.3400000000000001 106.263 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.768 ' HG2' ' HB2' ' A' ' 100' ' ' LEU 0.258 0.0 OUTLIER -69.33 -25.15 64.06 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 114.664 -1.153 . . . . 1.98 109.16 176.477 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -12.78 60.87 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.559 1.171 . . . . 2.2599999999999998 108.576 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -88.85 -33.59 17.31 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.695 -1.594 . . . . 3.5600000000000001 106.695 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.34 -58.26 2.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.161 -1.792 . . . . 1.1599999999999999 106.161 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 29' ' ' MET . . . 120.5 -90.07 0.46 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.807 -0.917 . . . . 0.38 110.807 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.7 ' CG2' ' O ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -120.28 24.41 10.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.583 -1.636 . . . . 1.27 106.583 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.763 ' HB2' ' CB ' ' A' ' 98' ' ' GLN . 1.0 OUTLIER 32.77 48.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.179 -1.786 . . . . 1.3600000000000001 106.179 -176.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.478 ' O ' HG11 ' A' ' 37' ' ' VAL . . . -62.49 73.42 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 CA-C-N 114.673 -1.149 . . . . 0.58999999999999997 111.236 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -162.55 -158.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.702 -0.881 . . . . 1.2 110.12 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 10.3 tttt -88.02 106.36 18.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.981 . . . . 2.7599999999999998 110.653 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -95.51 103.37 12.37 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.928 -1.107 . . . . 1.9299999999999999 111.414 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 43.9 Cg_endo -71.97 -166.37 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.496 1.464 . . . . 1.0700000000000001 112.696 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' HB2' ' N ' ' A' ' 1' ' ' ALA . . . -148.59 -42.1 0.15 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 1.6599999999999999 111.211 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.446 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 4.9 p -54.56 102.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.276 -0.89 . . . . 2.04 108.91 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 62.4 44.59 7.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.767 -0.827 . . . . 1.3300000000000001 108.767 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.99 59.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.739 -0.6 . . . . 3.54 110.036 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.57 ' O ' ' HB3' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -116.08 -145.57 0.39 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.288 -0.882 . . . . 1.6299999999999999 108.786 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.669 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 49.7 p90 171.47 173.84 0.08 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 120.384 1.447 . . . . 2.1299999999999999 112.001 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.794 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -100.18 143.51 30.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.473 -1.306 . . . . 1.1000000000000001 107.473 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.687 ' O ' ' HA ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -96.55 76.55 2.88 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.288 -0.883 . . . . 0.5 111.554 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 7' ' ' GLY . . . -78.29 48.1 3.04 Favored Glycine 0 N--CA 1.504 3.175 0 N-CA-C 108.933 -1.667 . . . . 0.39000000000000001 108.933 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 174.14 -168.4 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.032 -0.729 . . . . 1.1100000000000001 109.032 -179.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 53' ' ' THR . 19.8 p-80 -99.35 30.07 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.254 -0.904 . . . . 0.28999999999999998 109.229 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.654 ' O ' ' CG ' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -16.94 62.58 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 115.103 1.519 . . . . 2.1800000000000002 115.103 -177.005 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.677 ' N ' ' O ' ' A' ' 51' ' ' HIS . 31.3 m -18.65 82.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.369 -0.832 . . . . 1.3500000000000001 111.163 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -84.93 99.54 11.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.516 -1.365 . . . . 1.04 110.632 -176.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.413 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtp180 -96.56 104.69 16.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.156 -1.794 . . . . 2.7200000000000002 106.156 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.55 ' HB3' HG21 ' A' ' 96' ' ' VAL . 11.5 p90 -126.5 -175.29 3.35 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.454 1.65 . . . . 2.3199999999999998 115.454 -175.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.73 174.23 39.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 106.881 -2.487 . . . . 0.44 106.881 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' CG2' ' A' ' 75' ' ' VAL . 38.4 Cg_endo -66.0 124.11 12.19 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 108.561 -1.361 . . . . 0.52000000000000002 108.561 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 71' ' ' GLN . . . -65.82 123.3 19.42 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.846 -1.159 . . . . 1.0900000000000001 111.166 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 39.33 0.95 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 3.9900000000000002 110.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -138.72 68.02 1.39 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 2.2599999999999998 110.486 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -78.96 -20.1 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.906 . . . . 1.6699999999999999 109.817 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.7 t -79.5 71.02 6.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 2.23 110.102 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 1.068 ' SG ' ' SG ' ' A' ' 69' ' ' CYS . 2.5 m -84.38 169.64 14.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.112 -0.993 . . . . 1.03 110.7 -179.76 -34.07 -131.198 62.352 92.229 2.532 90.289 -158.163 42.314 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.14 -44.71 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.292 -0.88 . . . . 2.5499999999999998 109.636 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.659 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.9 ptm180 -165.75 32.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.773 -0.58 . . . . 4.3200000000000003 110.614 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CB ' ' O ' ' A' ' 66' ' ' ARG . 57.7 t80 113.28 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.519 2.988 0 C-N-CA 124.294 1.038 . . . . 2.2200000000000002 112.29 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HD2' ' C ' ' A' ' 66' ' ' ARG . 42.1 Cg_endo -67.46 58.03 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.674 0.828 . . . . 1.48 113.041 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 1.068 ' SG ' ' SG ' ' A' ' 64' ' ' CYS . 2.1 p -108.22 140.44 41.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.919 -1.113 . . . . 0.92000000000000004 109.203 177.503 42.314 -158.163 62.352 90.289 2.532 92.229 -131.198 -34.07 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.656 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 19.9 m-30 -80.19 14.84 1.74 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.859 -1.15 . . . . 2.3799999999999999 109.989 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 14.0 mm-40 34.3 25.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.641 0.978 . . . . 1.8300000000000001 113.641 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.836 ' CD2' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -169.24 -161.33 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.257 -1.527 . . . . 2.4100000000000001 112.586 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.29 21.85 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.124 0.487 . . . . 1.25 110.668 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.442 HG21 ' CZ ' ' A' ' 72' ' ' TYR . 5.3 p 61.92 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.843 0.83 . . . . 1.1000000000000001 112.575 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' CG2' ' HD2' ' A' ' 58' ' ' PRO . 25.1 t -113.13 -1.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.115 -0.99 . . . . 1.27 110.198 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.6 111.14 0.98 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 109.629 -1.388 . . . . 0.41999999999999998 109.629 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -77.09 158.43 30.48 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.94 -1.33 . . . . 2.52 112.767 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.712 ' CG1' ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -130.79 87.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 104.95 -2.241 . . . . 1.0800000000000001 104.95 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.701 ' CB ' ' CD ' ' A' ' 80' ' ' PRO . . . -50.82 -77.91 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 114.773 1.397 . . . . 1.0900000000000001 114.773 -174.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.701 ' CD ' ' CB ' ' A' ' 79' ' ' ALA . 44.0 Cg_endo -70.49 83.47 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.06 1.84 . . . . 0.33000000000000002 113.402 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.652 ' HA3' HD22 ' A' ' 87' ' ' LEU . . . 45.34 23.24 0.73 Allowed Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.901 -0.88 . . . . 0.34000000000000002 110.901 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.712 ' HA ' ' CG1' ' A' ' 78' ' ' VAL . . . 69.15 23.88 6.27 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.873 -0.781 . . . . 1.1200000000000001 110.971 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 169.62 -66.49 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.469 -0.937 . . . . 2.3999999999999999 108.469 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.648 ' HG ' HD21 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -120.75 135.73 55.06 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.551 -0.907 . . . . 1.29 108.551 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -77.71 41.48 0.34 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.468 -1.395 . . . . 3.4900000000000002 112.233 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.687 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -164.57 81.41 0.39 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.897 -1.127 . . . . 1.52 110.805 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.699 ' HB2' ' HD2' ' A' ' 88' ' ' PRO . 0.3 OUTLIER -171.27 179.04 0.7 Allowed Pre-proline 0 N--CA 1.51 2.541 0 C-N-CA 119.199 -1.0 . . . . 1.51 112.921 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 87' ' ' LEU . 43.0 Cg_endo -70.31 114.4 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.006 1.138 . . . . 0.69999999999999996 111.189 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.484 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -87.21 135.68 34.52 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.276 -0.89 . . . . 1.55 113.245 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.411 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 57.1 Cg_endo -100.33 -157.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 123.623 2.882 . . . . 0.38 112.516 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 92' ' ' ALA . . . 165.43 -94.97 0.11 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.284 -1.527 . . . . 1.49 109.284 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 91' ' ' GLY . . . 77.92 100.28 0.07 Allowed 'General case' 0 N--CA 1.517 2.912 0 N-CA-C 112.597 0.591 . . . . 1.3400000000000001 112.597 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.7 m 51.08 19.89 0.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-O 122.381 1.086 . . . . 2.02 111.775 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 91' ' ' GLY . 11.7 p -109.81 142.13 23.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 122.661 1.22 . . . . 2.1800000000000002 109.669 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.836 HG22 ' CD2' ' A' ' 72' ' ' TYR . 12.1 t -85.85 161.15 19.22 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.361 -1.348 . . . . 2.2599999999999998 107.361 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.662 ' HB ' ' HB3' ' A' ' 39' ' ' LEU . 1.2 t -159.2 132.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 117.657 -1.617 . . . . 1.3500000000000001 111.489 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.564 ' CA ' HG22 ' A' ' 34' ' ' THR . . . -89.64 76.61 1.72 Allowed Glycine 0 C--N 1.297 -1.598 0 N-CA-C 104.949 -3.261 . . . . 0.59999999999999998 104.949 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.763 ' CB ' ' HB2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -65.66 113.16 4.04 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.919 -0.712 . . . . 2.4399999999999999 112.374 -177.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.658 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -119.75 125.71 49.29 Favored 'General case' 0 C--N 1.276 -2.601 0 C-N-CA 116.813 -1.955 . . . . 1.1399999999999999 111.433 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.768 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 0.9 OUTLIER -119.88 50.08 1.32 Allowed 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 114.002 -1.453 . . . . 1.1399999999999999 110.312 -177.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.48 -32.23 7.51 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.562 -1.815 . . . . 0.32000000000000001 108.562 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 12.0 t0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.97 -0.538 . . . . 1.1899999999999999 110.997 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' N ' ' HB1' ' A' ' 41' ' ' ALA . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.339 0.114 . . . . 4.1299999999999999 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 42.3 Cg_endo -70.77 67.26 2.34 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.973 1.512 . . . . 2.48 110.662 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 45.1 m -102.73 -10.97 18.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.967 -1.083 . . . . 1.9099999999999999 111.981 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 1.059 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -64.99 166.63 11.83 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.964 -1.085 . . . . 1.21 110.116 179.542 -132.006 -110.009 -168.068 116.8 2.478 120.178 76.172 56.588 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.769 ' HG3' HD13 ' A' ' 17' ' ' LEU . 55.0 Cg_endo -81.28 -111.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.559 1.726 0 O-C-N 122.936 0.966 . . . . 1.8999999999999999 110.305 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.632 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -176.64 139.1 0.3 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.663 -1.273 . . . . 2.2999999999999998 110.208 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 49' ' ' GLY . . . 146.35 -39.42 1.11 Allowed Glycine 0 N--CA 1.51 3.595 0 C-N-CA 120.135 -1.031 . . . . 0.44 111.392 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 25' ' ' PRO . 17.9 m -152.33 172.28 16.71 Favored 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 106.554 -1.647 . . . . 0.33000000000000002 106.554 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.942 HD22 ' SD ' ' A' ' 29' ' ' MET . 0.5 OUTLIER -76.52 74.28 3.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.752 -1.179 . . . . 0.68000000000000005 108.774 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 1.059 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 24.3 p -78.79 93.46 4.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.796 -1.19 . . . . 0.28000000000000003 111.122 -178.482 56.588 76.172 -168.068 120.178 2.478 116.8 -110.009 -132.006 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 46' ' ' PHE . 21.1 p -77.23 150.29 35.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.671 -0.643 . . . . 0.51000000000000001 109.87 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.77 ' CG ' ' HA ' ' A' ' 17' ' ' LEU . 51.5 p90 -160.16 154.02 22.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.773 -1.205 . . . . 1.29 112.375 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.703 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 4.0 p -112.52 66.97 0.65 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.253 0.549 . . . . 0.81999999999999995 110.085 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 32.41 0.05 OUTLIER Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.489 -1.339 . . . . 0.89000000000000001 112.554 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.572 ' HA ' ' HE2' ' A' ' 12' ' ' TYR . 5.6 p 39.7 104.98 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.444 0 CA-C-N 118.562 1.181 . . . . 1.1499999999999999 113.583 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 3' ' ' SER . . . 113.41 28.19 3.36 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.169 -1.972 . . . . 0.66000000000000003 108.169 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.809 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 58.63 21.14 8.42 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.482 1.134 . . . . 1.3 109.325 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 35.2 t -98.65 -155.01 0.48 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 1.4299999999999999 111.223 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.15 -132.27 33.42 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 109.064 -1.614 . . . . 0.59999999999999998 109.064 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' SER . . . -74.0 71.22 1.57 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.931 -1.335 . . . . 0.57999999999999996 108.451 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.0 124.18 28.01 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.066 0.936 . . . . 2.77 113.048 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.65 165.74 20.25 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.98 -0.748 . . . . 0.66000000000000003 108.98 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.835 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.48 133.64 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.39 -1.444 . . . . 0.59999999999999998 112.351 -178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.089 HG23 ' HB2' ' A' ' 28' ' ' ASP . 6.9 mm -133.11 89.86 32.47 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 118.474 -1.29 . . . . 1.1799999999999999 110.315 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 49.3 Cg_endo -72.57 73.99 2.77 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.013 -1.572 . . . . 0.35999999999999999 108.013 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 50' ' ' THR . . . 35.1 68.92 0.18 Allowed 'General case' 0 N--CA 1.517 2.883 0 N-CA-C 109.572 -0.529 . . . . 0.37 109.572 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 t -164.0 -52.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 O-C-N 120.822 -1.174 . . . . 1.3700000000000001 111.298 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 1.089 ' HB2' HG23 ' A' ' 24' ' ' ILE . 3.3 m-20 -69.94 -26.03 63.94 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.263 -1.755 . . . . 1.3400000000000001 106.263 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.942 ' SD ' HD22 ' A' ' 9' ' ' LEU 0.258 0.0 OUTLIER -69.33 -25.15 64.06 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 114.664 -1.153 . . . . 1.46 109.16 176.477 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -12.78 60.87 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.559 1.171 . . . . 2.2599999999999998 108.576 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -88.85 -33.59 17.31 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.695 -1.594 . . . . 3.0299999999999998 106.695 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.34 -58.26 2.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.161 -1.792 . . . . 0.42999999999999999 106.161 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 29' ' ' MET . . . 120.5 -90.07 0.46 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.807 -0.917 . . . . 0.34999999999999998 110.807 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.7 ' CG2' ' O ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -120.28 24.41 10.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.583 -1.636 . . . . 0.68999999999999995 106.583 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.807 ' HB2' ' CB ' ' A' ' 98' ' ' GLN . 1.0 OUTLIER 32.77 48.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.179 -1.786 . . . . 1.3600000000000001 106.179 -176.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 37' ' ' VAL . . . -62.49 73.42 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 CA-C-N 114.673 -1.149 . . . . 0.52000000000000002 111.236 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -162.55 -158.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.702 -0.881 . . . . 0.58999999999999997 110.12 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.756 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 10.3 tttt -88.02 106.36 18.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.981 . . . . 2.3799999999999999 110.653 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -95.51 103.37 12.37 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.928 -1.107 . . . . 1.3400000000000001 111.414 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 43.9 Cg_endo -71.97 -166.37 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.496 1.464 . . . . 0.85999999999999999 112.696 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 92' ' ' ALA . . . -148.59 -42.1 0.15 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 1.23 111.211 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 p -54.56 102.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.276 -0.89 . . . . 1.6599999999999999 108.91 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 62.4 44.59 7.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.767 -0.827 . . . . 0.60999999999999999 108.767 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.99 59.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.739 -0.6 . . . . 2.8700000000000001 110.036 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -116.08 -145.57 0.39 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.288 -0.882 . . . . 1.22 108.786 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 49.7 p90 171.47 173.84 0.08 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 120.384 1.447 . . . . 1.22 112.001 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.794 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -100.18 143.51 30.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.473 -1.306 . . . . 0.40000000000000002 107.473 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -96.55 76.55 2.88 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.288 -0.883 . . . . 0.41999999999999998 111.554 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 50' ' ' THR . . . -78.29 48.1 3.04 Favored Glycine 0 N--CA 1.504 3.175 0 N-CA-C 108.933 -1.667 . . . . 0.33000000000000002 108.933 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.907 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 174.14 -168.4 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.032 -0.729 . . . . 0.38 109.032 -179.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 53' ' ' THR . 27.9 p80 -99.35 30.07 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.254 -0.904 . . . . 0.26000000000000001 109.229 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -16.94 62.58 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 115.103 1.519 . . . . 1.26 115.103 -177.005 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 m -18.65 82.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.369 -0.832 . . . . 0.82999999999999996 111.163 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -84.93 99.54 11.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.516 -1.365 . . . . 0.23999999999999999 110.632 -176.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtp180 -96.56 104.69 16.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.156 -1.794 . . . . 2.2400000000000002 106.156 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' A' ' 54' ' ' LEU . 11.5 p90 -126.5 -175.29 3.35 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.454 1.65 . . . . 1.5 115.454 -175.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.785 ' O ' HG22 ' A' ' 95' ' ' THR . . . 171.73 174.23 39.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 106.881 -2.487 . . . . 0.34999999999999998 106.881 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' HG21 ' A' ' 75' ' ' VAL . 38.4 Cg_endo -66.0 124.11 12.19 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 108.561 -1.361 . . . . 0.42999999999999999 108.561 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLN . . . -65.82 123.3 19.42 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.846 -1.159 . . . . 0.44 111.166 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 39.33 0.95 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 3.4100000000000001 110.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 8.9 mmtt -138.72 68.02 1.39 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 1.77 110.486 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -78.96 -20.1 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.906 . . . . 1.1000000000000001 109.817 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 63' ' ' THR . 6.7 t -79.5 71.02 6.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 1.8 110.102 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 69' ' ' CYS . 2.5 m -84.38 169.64 14.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.112 -0.993 . . . . 1.03 110.7 -179.76 -34.07 -131.198 62.352 92.229 2.532 90.289 -158.163 42.314 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.14 -44.71 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.292 -0.88 . . . . 2.0 109.636 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.659 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.9 ptm180 -165.75 32.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.773 -0.58 . . . . 3.7599999999999998 110.614 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CB ' ' O ' ' A' ' 66' ' ' ARG . 57.7 t80 113.28 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.519 2.988 0 C-N-CA 124.294 1.038 . . . . 1.46 112.29 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 66' ' ' ARG . 42.1 Cg_endo -67.46 58.03 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.674 0.828 . . . . 1.26 113.041 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 64' ' ' CYS . 2.1 p -108.22 140.44 41.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.919 -1.113 . . . . 0.92000000000000004 109.203 177.503 42.314 -158.163 62.352 90.289 2.532 92.229 -131.198 -34.07 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 19.9 m-30 -80.19 14.84 1.74 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.859 -1.15 . . . . 1.53 109.989 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 14.0 mm-40 34.3 25.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.641 0.978 . . . . 1.1299999999999999 113.641 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 1.289 ' CB ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -169.24 -161.33 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.257 -1.527 . . . . 1.55 112.586 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.29 21.85 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.124 0.487 . . . . 0.48999999999999999 110.668 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.818 HG22 ' CZ ' ' A' ' 72' ' ' TYR . 5.3 p 61.92 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.843 0.83 . . . . 0.46999999999999997 112.575 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 58' ' ' PRO . 25.1 t -113.13 -1.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.115 -0.99 . . . . 0.56999999999999995 110.198 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.6 111.14 0.98 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 109.629 -1.388 . . . . 0.37 109.629 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -77.09 158.43 30.48 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.94 -1.33 . . . . 2.0299999999999998 112.767 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -130.79 87.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 104.95 -2.241 . . . . 0.29999999999999999 104.95 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 80' ' ' PRO . . . -50.82 -77.91 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 114.773 1.397 . . . . 0.28000000000000003 114.773 -174.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 79' ' ' ALA . 44.0 Cg_endo -70.49 83.47 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.06 1.84 . . . . 0.29999999999999999 113.402 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . 45.34 23.24 0.73 Allowed Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.901 -0.88 . . . . 0.34000000000000002 110.901 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.802 ' HA ' HG12 ' A' ' 78' ' ' VAL . . . 69.15 23.88 6.27 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.873 -0.781 . . . . 0.58999999999999997 110.971 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 169.62 -66.49 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.469 -0.937 . . . . 2.0299999999999998 108.469 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.997 ' CD2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -120.75 135.73 55.06 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.551 -0.907 . . . . 0.55000000000000004 108.551 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -77.71 41.48 0.34 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.468 -1.395 . . . . 2.8100000000000001 112.233 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -164.57 81.41 0.39 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.897 -1.127 . . . . 1.1200000000000001 110.805 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.997 HD22 ' CD2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -171.27 179.04 0.7 Allowed Pre-proline 0 N--CA 1.51 2.541 0 C-N-CA 119.199 -1.0 . . . . 0.85999999999999999 112.921 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.706 ' HD2' ' HB2' ' A' ' 87' ' ' LEU . 43.0 Cg_endo -70.31 114.4 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.006 1.138 . . . . 0.68999999999999995 111.189 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -87.21 135.68 34.52 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.276 -0.89 . . . . 1.05 113.245 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 89' ' ' SER . 57.1 Cg_endo -100.33 -157.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 123.623 2.882 . . . . 0.32000000000000001 112.516 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.675 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . 165.43 -94.97 0.11 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.284 -1.527 . . . . 1.49 109.284 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 91' ' ' GLY . . . 77.92 100.28 0.07 Allowed 'General case' 0 N--CA 1.517 2.912 0 N-CA-C 112.597 0.591 . . . . 1.04 112.597 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 93' ' ' THR . 18.7 m 51.08 19.89 0.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-O 122.381 1.086 . . . . 1.4199999999999999 111.775 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.477 HG11 ' HA2' ' A' ' 91' ' ' GLY . 11.7 p -109.81 142.13 23.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 122.661 1.22 . . . . 1.5800000000000001 109.669 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.289 HG21 ' CB ' ' A' ' 72' ' ' TYR . 12.1 t -85.85 161.15 19.22 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.361 -1.348 . . . . 1.6399999999999999 107.361 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 39' ' ' LEU . 1.2 t -159.2 132.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 117.657 -1.617 . . . . 0.71999999999999997 111.489 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.595 ' CA ' HG23 ' A' ' 34' ' ' THR . . . -89.64 76.61 1.72 Allowed Glycine 0 C--N 1.297 -1.598 0 N-CA-C 104.949 -3.261 . . . . 0.47999999999999998 104.949 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.807 ' CB ' ' HB2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -65.66 113.16 4.04 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.919 -0.712 . . . . 2.4399999999999999 112.374 -177.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -119.75 125.71 49.29 Favored 'General case' 0 C--N 1.276 -2.601 0 C-N-CA 116.813 -1.955 . . . . 1.1399999999999999 111.433 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.808 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 0.9 OUTLIER -119.88 50.08 1.32 Allowed 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 114.002 -1.453 . . . . 0.37 110.312 -177.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.48 -32.23 7.51 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.562 -1.815 . . . . 0.28999999999999998 108.562 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 12.0 t0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.97 -0.538 . . . . 1.1899999999999999 110.997 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' N ' ' HB1' ' A' ' 41' ' ' ALA . . . . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 120.339 0.114 . . . . 4.1299999999999999 110.81 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 42.3 Cg_endo -70.77 67.26 2.34 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 O-C-N 123.973 1.512 . . . . 2.48 110.662 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.44 ' O ' ' HA2' ' A' ' 16' ' ' GLY . 45.1 m -102.73 -10.97 18.72 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.967 -1.083 . . . . 1.9099999999999999 111.981 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 1.059 ' SG ' ' SG ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -64.99 166.63 11.83 Favored Pre-proline 0 N--CA 1.501 2.122 0 O-C-N 120.964 -1.085 . . . . 1.21 110.116 179.542 -132.006 -110.009 -168.068 116.8 2.478 120.178 76.172 56.588 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.769 ' HG3' HD13 ' A' ' 17' ' ' LEU . 55.0 Cg_endo -81.28 -111.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.559 1.726 0 O-C-N 122.936 0.966 . . . . 1.8999999999999999 110.305 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.632 ' HA ' ' HB1' ' A' ' 47' ' ' ALA . . . -176.64 139.1 0.3 Allowed 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.663 -1.273 . . . . 2.2999999999999998 110.208 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 49' ' ' GLY . . . 146.35 -39.42 1.11 Allowed Glycine 0 N--CA 1.51 3.595 0 C-N-CA 120.135 -1.031 . . . . 0.44 111.392 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 25' ' ' PRO . 17.9 m -152.33 172.28 16.71 Favored 'General case' 0 N--CA 1.51 2.541 0 N-CA-C 106.554 -1.647 . . . . 0.33000000000000002 106.554 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.942 HD22 ' SD ' ' A' ' 29' ' ' MET . 0.5 OUTLIER -76.52 74.28 3.25 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 118.752 -1.179 . . . . 0.68000000000000005 108.774 179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 1.059 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 24.3 p -78.79 93.46 4.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.796 -1.19 . . . . 0.28000000000000003 111.122 -178.482 56.588 76.172 -168.068 120.178 2.478 116.8 -110.009 -132.006 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.642 ' HA ' ' HB3' ' A' ' 46' ' ' PHE . 21.1 p -77.23 150.29 35.4 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.671 -0.643 . . . . 0.51000000000000001 109.87 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.77 ' CG ' ' HA ' ' A' ' 17' ' ' LEU . 51.5 p90 -160.16 154.02 22.88 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.773 -1.205 . . . . 1.29 112.375 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.703 ' HB3' ' HB3' ' A' ' 20' ' ' ALA . 4.0 p -112.52 66.97 0.65 Allowed 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.253 0.549 . . . . 0.81999999999999995 110.085 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.85 32.41 0.05 OUTLIER Glycine 0 N--CA 1.502 3.056 0 C-N-CA 119.489 -1.339 . . . . 0.89000000000000001 112.554 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.572 ' HA ' ' HE2' ' A' ' 12' ' ' TYR . 5.6 p 39.7 104.98 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.444 0 CA-C-N 118.562 1.181 . . . . 1.1499999999999999 113.583 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 3' ' ' SER . . . 113.41 28.19 3.36 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 108.169 -1.972 . . . . 0.66000000000000003 108.169 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.809 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 58.63 21.14 8.42 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.482 1.134 . . . . 1.3 109.325 -178.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' TYR . 35.2 t -98.65 -155.01 0.48 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 1.4299999999999999 111.223 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.15 -132.27 33.42 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 109.064 -1.614 . . . . 0.59999999999999998 109.064 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' HB3' ' HB3' ' A' ' 13' ' ' SER . . . -74.0 71.22 1.57 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.931 -1.335 . . . . 0.57999999999999996 108.451 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.0 124.18 28.01 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.066 0.936 . . . . 2.77 113.048 -177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.65 165.74 20.25 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 108.98 -0.748 . . . . 0.66000000000000003 108.98 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.835 ' O ' HD13 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -133.48 133.64 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 120.39 -1.444 . . . . 0.59999999999999998 112.351 -178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.089 HG23 ' HB2' ' A' ' 28' ' ' ASP . 6.9 mm -133.11 89.86 32.47 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 118.474 -1.29 . . . . 1.1799999999999999 110.315 175.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' HB3' ' OG ' ' A' ' 8' ' ' SER . 49.3 Cg_endo -72.57 73.99 2.77 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.013 -1.572 . . . . 0.35999999999999999 108.013 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.907 ' HB2' HG21 ' A' ' 50' ' ' THR . . . 35.1 68.92 0.18 Allowed 'General case' 0 N--CA 1.517 2.883 0 N-CA-C 109.572 -0.529 . . . . 0.37 109.572 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.9 t -164.0 -52.93 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 O-C-N 120.822 -1.174 . . . . 1.3700000000000001 111.298 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 1.089 ' HB2' HG23 ' A' ' 24' ' ' ILE . 3.3 m-20 -69.94 -26.03 63.94 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.263 -1.755 . . . . 1.3400000000000001 106.263 176.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.942 ' SD ' HD22 ' A' ' 9' ' ' LEU 0.258 0.0 OUTLIER -69.33 -25.15 64.06 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-N 114.664 -1.153 . . . . 1.46 109.16 176.477 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.58 -12.78 60.87 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.559 1.171 . . . . 2.2599999999999998 108.576 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -88.85 -33.59 17.31 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 106.695 -1.594 . . . . 3.0299999999999998 106.695 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.34 -58.26 2.75 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.161 -1.792 . . . . 0.42999999999999999 106.161 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 29' ' ' MET . . . 120.5 -90.07 0.46 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.807 -0.917 . . . . 0.34999999999999998 110.807 176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.7 ' CG2' ' O ' ' A' ' 34' ' ' THR . 0.6 OUTLIER -120.28 24.41 10.42 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 106.583 -1.636 . . . . 0.68999999999999995 106.583 179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.807 ' HB2' ' CB ' ' A' ' 98' ' ' GLN . 1.0 OUTLIER 32.77 48.4 0.13 Allowed 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 106.179 -1.786 . . . . 1.3600000000000001 106.179 -176.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' C ' HG22 ' A' ' 37' ' ' VAL . . . -62.49 73.42 0.02 OUTLIER Glycine 0 N--CA 1.489 2.169 0 CA-C-N 114.673 -1.149 . . . . 0.52000000000000002 111.236 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' C ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -162.55 -158.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.702 -0.881 . . . . 0.58999999999999997 110.12 -179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.756 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 10.3 tttt -88.02 106.36 18.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.13 -0.981 . . . . 2.3799999999999999 110.653 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.706 ' HB3' ' HB ' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -95.51 103.37 12.37 Favored Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 120.928 -1.107 . . . . 1.3400000000000001 111.414 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 38' ' ' LYS . 43.9 Cg_endo -71.97 -166.37 0.25 Allowed 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.496 1.464 . . . . 0.85999999999999999 112.696 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' HB2' ' H ' ' A' ' 92' ' ' ALA . . . -148.59 -42.1 0.15 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.49 -0.756 . . . . 1.23 111.211 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 4.9 p -54.56 102.81 0.07 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.276 -0.89 . . . . 1.6599999999999999 108.91 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.607 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 62.4 44.59 7.14 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.767 -0.827 . . . . 0.60999999999999999 108.767 -177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.99 59.22 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.739 -0.6 . . . . 2.8700000000000001 110.036 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.592 ' O ' ' HA ' ' A' ' 11' ' ' THR . 0.2 OUTLIER -116.08 -145.57 0.39 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.288 -0.882 . . . . 1.22 108.786 179.026 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.658 ' HA ' ' O ' ' A' ' 10' ' ' CYS . 49.7 p90 171.47 173.84 0.08 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 120.384 1.447 . . . . 1.22 112.001 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.794 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . . . -100.18 143.51 30.3 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.473 -1.306 . . . . 0.40000000000000002 107.473 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' A' ' 86' ' ' SER . 0.7 OUTLIER -96.55 76.55 2.88 Favored 'General case' 0 C--N 1.284 -2.246 0 O-C-N 121.288 -0.883 . . . . 0.41999999999999998 111.554 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 50' ' ' THR . . . -78.29 48.1 3.04 Favored Glycine 0 N--CA 1.504 3.175 0 N-CA-C 108.933 -1.667 . . . . 0.33000000000000002 108.933 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.907 HG21 ' HB2' ' A' ' 26' ' ' ALA . 0.1 OUTLIER 174.14 -168.4 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 N-CA-C 109.032 -0.729 . . . . 0.38 109.032 -179.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 53' ' ' THR . 19.8 p-80 -99.35 30.07 3.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.254 -0.904 . . . . 0.26000000000000001 109.229 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.662 ' HA ' ' O ' ' A' ' 99' ' ' ASP . 0.1 OUTLIER -16.94 62.58 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.25 0 N-CA-C 115.103 1.519 . . . . 1.26 115.103 -177.005 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 99' ' ' ASP . 31.3 m -18.65 82.73 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.369 -0.832 . . . . 0.82999999999999996 111.163 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -84.93 99.54 11.03 Favored 'General case' 0 N--CA 1.48 1.06 0 O-C-N 120.516 -1.365 . . . . 0.23999999999999999 110.632 -176.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' CG ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtp180 -96.56 104.69 16.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 106.156 -1.794 . . . . 2.2400000000000002 106.156 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.543 ' CD1' HD11 ' A' ' 54' ' ' LEU . 11.5 p90 -126.5 -175.29 3.35 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.454 1.65 . . . . 1.5 115.454 -175.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.785 ' O ' HG22 ' A' ' 95' ' ' THR . . . 171.73 174.23 39.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 106.881 -2.487 . . . . 0.34999999999999998 106.881 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.695 ' HD2' HG21 ' A' ' 75' ' ' VAL . 38.4 Cg_endo -66.0 124.11 12.19 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 N-CA-C 108.561 -1.361 . . . . 0.42999999999999999 108.561 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 71' ' ' GLN . . . -65.82 123.3 19.42 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 120.846 -1.159 . . . . 0.44 111.166 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -147.73 39.33 0.95 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.599 -0.688 . . . . 3.4100000000000001 110.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.433 ' HB2' ' HA ' ' A' ' 71' ' ' GLN . 8.9 mmtt -138.72 68.02 1.39 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.28 -0.887 . . . . 1.77 110.486 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -78.96 -20.1 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 O-C-N 121.251 -0.906 . . . . 1.1000000000000001 109.817 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 63' ' ' THR . 6.7 t -79.5 71.02 6.06 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.284 -0.885 . . . . 1.8 110.102 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 69' ' ' CYS . 2.5 m -84.38 169.64 14.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.112 -0.993 . . . . 1.03 110.7 -179.76 -34.07 -131.198 62.352 92.229 2.532 90.289 -158.163 42.314 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.6 t -79.14 -44.71 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.292 -0.88 . . . . 2.0 109.636 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.659 ' O ' ' CB ' ' A' ' 67' ' ' PHE . 1.9 ptm180 -165.75 32.45 0.05 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.773 -0.58 . . . . 3.7599999999999998 110.614 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.659 ' CB ' ' O ' ' A' ' 66' ' ' ARG . 57.7 t80 113.28 -44.9 0.0 OUTLIER Pre-proline 0 N--CA 1.519 2.988 0 C-N-CA 124.294 1.038 . . . . 1.46 112.29 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 66' ' ' ARG . 42.1 Cg_endo -67.46 58.03 0.69 Allowed 'Trans proline' 0 N--CA 1.498 1.748 0 O-C-N 122.674 0.828 . . . . 1.26 113.041 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.994 ' SG ' ' SG ' ' A' ' 64' ' ' CYS . 2.1 p -108.22 140.44 41.46 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.919 -1.113 . . . . 0.92000000000000004 109.203 177.503 42.314 -158.163 62.352 90.289 2.532 92.229 -131.198 -34.07 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 72' ' ' TYR . 19.9 m-30 -80.19 14.84 1.74 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.859 -1.15 . . . . 1.53 109.989 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.539 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 14.0 mm-40 34.3 25.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.641 0.978 . . . . 1.1299999999999999 113.641 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 1.289 ' CB ' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -169.24 -161.33 0.3 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.257 -1.527 . . . . 1.55 112.586 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -141.29 21.85 2.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.124 0.487 . . . . 0.48999999999999999 110.668 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.818 HG22 ' CZ ' ' A' ' 72' ' ' TYR . 5.3 p 61.92 114.55 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.852 0 CA-C-O 121.843 0.83 . . . . 0.46999999999999997 112.575 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.695 HG21 ' HD2' ' A' ' 58' ' ' PRO . 25.1 t -113.13 -1.37 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.115 -0.99 . . . . 0.56999999999999995 110.198 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 138.6 111.14 0.98 Allowed Glycine 0 N--CA 1.5 2.958 0 N-CA-C 109.629 -1.388 . . . . 0.37 109.629 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.422 ' HB3' ' CG ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -77.09 158.43 30.48 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 120.94 -1.33 . . . . 2.0299999999999998 112.767 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.802 HG12 ' HA ' ' A' ' 82' ' ' ALA . 0.0 OUTLIER -130.79 87.36 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 104.95 -2.241 . . . . 0.29999999999999999 104.95 174.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 80' ' ' PRO . . . -50.82 -77.91 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 114.773 1.397 . . . . 0.28000000000000003 114.773 -174.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 79' ' ' ALA . 44.0 Cg_endo -70.49 83.47 0.83 Allowed 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.06 1.84 . . . . 0.29999999999999999 113.402 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.587 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . 45.34 23.24 0.73 Allowed Glycine 0 N--CA 1.502 3.078 0 N-CA-C 110.901 -0.88 . . . . 0.34000000000000002 110.901 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.802 ' HA ' HG12 ' A' ' 78' ' ' VAL . . . 69.15 23.88 6.27 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.873 -0.781 . . . . 0.58999999999999997 110.971 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 169.62 -66.49 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 N-CA-C 108.469 -0.937 . . . . 2.0299999999999998 108.469 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.997 ' CD2' HD22 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -120.75 135.73 55.06 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.551 -0.907 . . . . 0.55000000000000004 108.551 178.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.8 ptt180 -77.71 41.48 0.34 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.468 -1.395 . . . . 2.8100000000000001 112.233 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.706 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 0.1 OUTLIER -164.57 81.41 0.39 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.897 -1.127 . . . . 1.1200000000000001 110.805 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.997 HD22 ' CD2' ' A' ' 84' ' ' LEU . 0.3 OUTLIER -171.27 179.04 0.7 Allowed Pre-proline 0 N--CA 1.51 2.541 0 C-N-CA 119.199 -1.0 . . . . 0.85999999999999999 112.921 -179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.706 ' HD2' ' HB2' ' A' ' 87' ' ' LEU . 43.0 Cg_endo -70.31 114.4 3.78 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 121.006 1.138 . . . . 0.68999999999999995 111.189 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -87.21 135.68 34.52 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.276 -0.89 . . . . 1.05 113.245 -179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 89' ' ' SER . 57.1 Cg_endo -100.33 -157.75 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 123.623 2.882 . . . . 0.32000000000000001 112.516 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.675 ' O ' ' HB3' ' A' ' 92' ' ' ALA . . . 165.43 -94.97 0.11 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 109.284 -1.527 . . . . 1.49 109.284 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.675 ' HB3' ' O ' ' A' ' 91' ' ' GLY . . . 77.92 100.28 0.07 Allowed 'General case' 0 N--CA 1.517 2.912 0 N-CA-C 112.597 0.591 . . . . 1.04 112.597 178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 93' ' ' THR . 18.7 m 51.08 19.89 0.76 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-O 122.381 1.086 . . . . 1.4199999999999999 111.775 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.477 HG11 ' HA2' ' A' ' 91' ' ' GLY . 11.7 p -109.81 142.13 23.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-O 122.661 1.22 . . . . 1.5800000000000001 109.669 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.289 HG21 ' CB ' ' A' ' 72' ' ' TYR . 12.1 t -85.85 161.15 19.22 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.361 -1.348 . . . . 1.6399999999999999 107.361 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.706 ' HB ' ' HB3' ' A' ' 39' ' ' LEU . 1.2 t -159.2 132.3 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 C-N-CA 117.657 -1.617 . . . . 0.71999999999999997 111.489 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.595 ' CA ' HG23 ' A' ' 34' ' ' THR . . . -89.64 76.61 1.72 Allowed Glycine 0 C--N 1.297 -1.598 0 N-CA-C 104.949 -3.261 . . . . 0.47999999999999998 104.949 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.807 ' CB ' ' HB2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER -65.66 113.16 4.04 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.919 -0.712 . . . . 2.4399999999999999 112.374 -177.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -119.75 125.71 49.29 Favored 'General case' 0 C--N 1.276 -2.601 0 C-N-CA 116.813 -1.955 . . . . 1.1399999999999999 111.433 178.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.808 ' HB2' ' HG2' ' A' ' 29' ' ' MET . 0.9 OUTLIER -119.88 50.08 1.32 Allowed 'General case' 0 N--CA 1.505 2.295 0 CA-C-N 114.002 -1.453 . . . . 0.37 110.312 -177.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.48 -32.23 7.51 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.562 -1.815 . . . . 0.28999999999999998 108.562 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.532 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 12.0 t0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 118.97 -0.538 . . . . 1.1899999999999999 110.997 179.385 . . . . . . . . 1 1 . 1 stop_ save_